MedPath

Pharmacokinetic Study of Topical Phenylephrine

Phase 1
Not yet recruiting
Conditions
Chemotherapy Induced Alopecia
Chemotherapy Side Effects
Registration Number
NCT07033845
Lead Sponsor
Applied Biology, Inc.
Brief Summary

Pharmacokinetic Study of Topical Phenylephrine

Detailed Description

A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Topical Phenylephrine Applied to the Scalp in Healthy Adult Females

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
24
Inclusion Criteria
  • Healthy females, age 18-55
  • BMI: 18-30 kg/m²
  • Fitzpatrick Skin Types I-IV (to standardize absorption risk)
  • Scalp free from irritation, dermatologic disease, or damage
  • Able to refrain from using other topical scalp products
Exclusion Criteria
  • History of cardiovascular disease, hypertension, or arrhythmia
  • Scalp infections, wounds, or significant hair loss
  • Recent use of medications that interfere with CYP enzymes or adrenergic systems
  • Known sensitivity to phenylephrine or ethanol
  • Positive drug screen or abnormal ECG at screening

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Pharmacokinetic profile of phenylephrineWeek [0,3]

Determine the amount of phenylephrine and its metabolites in serum daily scalp application of topical phenylephrine for a period of 3 weeks

Secondary Outcome Measures
NameTimeMethod
Safety and tolerability of phenylephrineWeek [0, 3]

Determine blood pressure and dermatological adverse events following daily scalp application of topical phenylephrine for a period of 3 weeks

Trial Locations

Locations (1)

University of Rome ("G. Marconi")

🇮🇹

Rome, Italy

University of Rome ("G. Marconi")
🇮🇹Rome, Italy
Andy Goren, MD
Contact
16507040850
clinicalstudies@appliedbiology.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.